Latest minority interest for NRSN: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
NeuroSense Therapeutics (NRSN) currently reports a minority interest of $0 as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore NeuroSense Therapeutics's minority interest history and peer comparisons.
NeuroSense Therapeutics's minority interest changed from $0 to $0 (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
NeuroSense Therapeutics reported $0 in minority interest as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics, and consider following NRSN for alerts when major investors trade the stock.